PAVmed (FRA:1P5) Cyclically Adjusted Book per Share: €-8.34 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1P5 PAVmed Inc FRA:1P5
35 GF Score
Price €4.13
GF Value €0.93
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PAVmed Cyclically Adjusted Book per Share?

PAVmed FRA:1P5 -2.25% 35 Cyclically Adjusted Book per Share is €-8.34 as of Mar. 2026. GuruFocus rates FRA:1P5 with a GF Score™ of 35/100 and a GF Value™ of €0.93 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PAVmed's adjusted book value per share for the three months ended in Mar. 2026 was €4.935. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-8.34 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-04), PAVmed's current stock price is €4.125. PAVmed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €-8.34. PAVmed's Cyclically Adjusted PB Ratio of today is .


PAVmed  (FRA:1P5) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PAVmed Cyclically Adjusted Book per Share Related Terms


PAVmed Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PAVmed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PAVmed Cyclically Adjusted Book per Share Chart

PAVmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -4.05 -12.63

PAVmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.57 -4.33 -6.39 -12.63 -8.34

FRA:1P5 vs BDMD, NSPR, TELA: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, PAVmed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PAVmed Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PAVmed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PAVmed's Cyclically Adjusted PB Ratio falls into.


FRA:1P5
35GF Score
PAVmed Inc FRA:1P5
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PAVmed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PAVmed's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.935/330.2130*330.2130
=4.935

Current CPI (Mar. 2026) = 330.2130.

PAVmed Quarterly Data

Book Value per Share CPI Adj_Book
201606 81.567 241.018 111.753
201609 33.967 241.428 46.458
201612 -10.067 241.432 -13.769
201703 -134.467 243.801 -182.127
201706 -149.833 244.955 -201.983
201709 -170.667 246.819 -228.331
201712 -102.500 246.524 -137.296
201803 -30.333 249.554 -40.137
201806 70.898 251.989 92.907
201809 24.492 252.439 32.038
201812 -63.683 251.233 -83.703
201903 -111.200 254.202 -144.451
201906 -43.053 256.143 -55.503
201909 -46.111 256.759 -59.303
201912 -61.200 256.974 -78.642
202003 -159.929 258.115 -204.601
202006 -114.877 257.797 -147.146
202009 -118.555 260.280 -150.409
202012 -3.704 260.474 -4.696
202103 221.365 264.877 275.968
202106 182.473 271.696 221.773
202109 147.027 274.310 176.990
202112 273.089 278.802 323.447
202203 204.394 287.504 234.757
202206 95.207 296.311 106.100
202209 31.156 296.808 34.663
202212 -55.633 296.797 -61.897
202303 -103.504 301.836 -113.235
202306 -131.568 305.109 -142.393
202309 -162.654 307.789 -174.504
202312 -182.196 306.746 -196.135
202403 -224.078 312.332 -236.906
202406 -225.226 314.175 -236.723
202409 -20.561 315.301 -21.533
202412 -14.879 315.605 -15.568
202503 30.970 319.799 31.979
202506 16.745 322.561 17.142
202509 9.378 324.800 9.534
202512 8.548 324.054 8.710
202603 4.935 330.213 4.935

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-8.34 mean?
PAVmed (FRA:1P5) has a Cyclically Adjusted Book per Share of €-8.34 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PAVmed and its competitors.
Is PAVmed's Cyclically Adjusted Book per Share too high?
PAVmed's current Cyclically Adjusted Book per Share is €-8.34. Overall, PAVmed has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PAVmed's Cyclically Adjusted Book per Share compare to BDMD and NSPR?
PAVmed's Cyclically Adjusted Book per Share of €-8.34 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PAVmed and its competitors. PAVmed's current Cyclically Adjusted Book per Share is €-8.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAVmed stock overvalued right now?
Based on GuruFocus' analysis, PAVmed (FRA:1P5) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.93, compared to a current price of €4.13 — trading 343.5% above its estimated fair value. The current Cyclically Adjusted Book per Share is €-8.34. PAVmed's overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PAVmed (FRA:1P5), the current Cyclically Adjusted Book per Share is €-8.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PAVmed (FRA:1P5) Overvalued in 2026?

Based on GuruFocus' analysis, PAVmed stock appears to be overvalued. The current stock price of €4.13 is trading 343.5% above its estimated GF Value™ of €0.93. GuruFocus considers PAVmed to be Significantly Overvalued.

Key valuation signals for FRA:1P5:

  • Cyclically Adjusted Book per Share: €-8.34
  • GF Value™: €0.93 vs. price of €4.13 (343.5% above fair value)
  • GF Score™: 35/100 with 6 warning signs

No single metric tells the full story. See the FRA:1P5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PAVmed Business Description

Other Exchanges PAVM:USA
Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
35GF Score

Get the complete analysis for FRA:1P5

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.13
Price
€0.93
GF Value